Search
Showing results for "early lung health"
Coronavirus disease 2019 (COVID-19) is an extremely contagious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early disease recognition of COVID-19 is crucial not only for prompt diagnosis and treatment of the patients, but also for effective public health surveillance and response.
Our researchers are involved in a new nationwide program aiming to better detect a child's risk of developing type 1 diabetes.
Airway surface liquid pH is not acidic in children with cystic fibrosis Modulation of airway surface liquid (ASL) pH has been proposed as a therapy
Pregnancy is associated with an alternatively activated phenotype of alveolar macrophage before infection
We describe recent "omic"-level findings, and examine how these findings have been systematically integrated to generate further insight
The present study aimed to clarify the effect of viral and bacterial co-detections on disease severity during paediatric acute respiratory infection (ARI).
In the longest reported follow-up of infants who received aP vaccine at birth, we found a trend to lower PT IgG antibodies post booster compared with receipt...
During exacerbations, when symptom and treatment burden are increased, individuals with cystic fibrosis (CF) are likely to prefer airway clearance techniques (ACTs) that require minimal effort. Therefore, in adults with CF who were hospitalised with an exacerbation, we sought to compare the effect of the MetaNeb with usual ACTs on respiratory function and expectorated sputum.
We aim to determine the contribute of bacteria and virus to childhood CAP to inform further development of effective strategies.
Everything you need to know to book tickets to our upcoming school holiday workshops in July held at Scitech!